VRXAVeraxa Biotech AG - Post de-SPAC
- Market cap
- $141.41M
- as of 2026-10-23
- Latest close
- $1.00
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
2 insiders bought $82.7K between Aug 27.
Under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-08-31
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Ziegler Christoph Samuel | Oct 20 | Oct 21 | P | 30,000 | $1.09 | Purchase +$32,700 | 37,932 | No | Form 4 |
| Antz Christoph RudigerChief Executive Officer | Aug 27 | Aug 31 | P | 5,000 | $1.53 | Purchase +$7,650 | 5,000 | No | Form 4 |
| Baumann Oliver Rolf | Aug 27 | Aug 31 | P | 50,000 | $1.50 | Purchase +$75,000 | 5,773,618 | No | Form 4 |